We're evaluating two decades of data on people diagnosed with Merkel Cell Carcinoma in 10 centers in Canada to empower healthcare professionals with the insights needed to provide excellent care.
Pan-Canadian Merkel Cell Carcinoma Cohort Study
FAQs
-
We are evaluating the management and outcomes of people diagnosed with Merkel Cell Carcinoma in Canada over the last two decades.
-
The research results will give healthcare professionals important information about how we can improve the care for people diagnosed with this rare skin cancer in Canada.
-
We conducted a retrospective cohort study of patients diagnosed with Merkel Cell Carcinoma at 10 Canadian university centers and across three Canadian provinces between 2000-2018. Retrospective data collection and analysis was completed between 2017-2022.
-
Item description
Follow our journey.
-
![]()
Study design
-
![]()
Data collection
It all begins with an idea. Maybe you want to launch a business. Maybe you want to turn a hobby into something more.
-
![]()
Data analysis
It all begins with an idea. Maybe you want to launch a business. Maybe you want to turn a hobby into something more.
-
![]()
Synthesis of conclusions
It all begins with an idea. Maybe you want to launch a business. Maybe you want to turn a hobby into something more.
Study Design
Data Collection